References

Breast cancer: pathogenesis and treatments

10.1038/s41392-024-02108-4 · 2025 · External reference

Insights into molecular classifications of triple-negative breast cancer: improving patient selection for treatment

10.1158/2159-8290.cd-18-1177 · 2019 · External reference

Triple-negative breast cancer molecular subtyping and treatment progress

10.1186/s13058-020-01296-5 · 2020 · External reference

Gene expression profiling and histopathological characterization of triple-negative/basal-like breast carcinomas

10.1186/bcr1771 · 2007 · External reference

Divide and conquer-targeted therapy for triple-negative breast cancer

10.3390/ijms26041396 · 2025 · External reference

Checkpoint inhibitors in triple-negative breast cancer (TNBC): where to go from here

10.1002/cncr.31272 · 2018 · External reference

Unraveling biomarker signatures in triple-negative breast cancer: a systematic review for targeted approaches

10.3390/ijms25052559 · 2024 · External reference

Biomarkers for predicting the efficacy of immune checkpoint inhibitors

10.7150/jca.65012 · 2022 · External reference

Immunotherapy in breast cancer

10.3390/ijms25147517 · 2024 · External reference

Spatial predictors of immunotherapy response in triple-negative breast cancer

10.1038/s41586-023-06498-3 · 2023 · External reference

FGFR blockade boosts T cell infiltration into triple-negative breast cancer by regulating cancer-associated fibroblasts

10.7150/thno.68972 · 2022 · External reference

The functional role of extracellular matrix proteins in cancer

10.3390/cancers14010238 · 2022 · External reference

Biology of the extracellular matrix: an overview

10.1097/ijg.0000000000000108 · 2014 · External reference

The mechanics of fibrillar collagen extracellular matrix

10.1016/j.xcrp.2021.100515 · 2021 · External reference

Evaluation of extracellular matrix composition to improve breast cancer modeling

10.1089/ten.tea.2020.0364 · 2021 · External reference

Voluntary exercise sensitizes cancer immunotherapy via the collagen inhibition-orchestrated inflammatory tumor immune microenvironment

10.1016/j.celrep.2024.114697 · 2024 · External reference

Immune modulatory properties of collagen in cancer

10.3389/fimmu.2021.791453 · 2021 · External reference

Conserved immuno-collagenic subtypes predict response to immune checkpoint blockade

10.1002/cac2.12538 · 2024 · External reference

Mammalian long-chain acyl-CoA synthetases

10.3181/0710-mr-287 · 2008 · External reference

Role of ACSL5 in fatty acid metabolism

10.1016/j.heliyon.2023.e13316 · 2023 · External reference

Fatty acid activation in carcinogenesis and cancer development: essential roles of long-chain acyl-CoA synthetases

10.3892/ol.2018.8843 · 2018 · External reference

Dietary elaidic acid boosts tumoral antigen presentation and cancer immunity via ACSL5

10.1016/j.cmet.2024.01.012 · 2024 · External reference

Mms2-Ubc13 covalently bound to ubiquitin reveals the structural basis of linkage-specific polyubiquitin chain formation

10.1038/nsmb1148 · 2006 · External reference

Ube2v1 positively regulates protein aggregation by modulating ubiquitin proteasome system performance partially through K63 ubiquitination

10.1161/circresaha.119.316444 · 2020 · External reference

E2 enzymes: more than just middle men

10.1038/cr.2016.35 · 2016 · External reference

Targeting the ubiquitin-proteasome system and recent advances in cancer therapy

10.3390/cells13010029 · 2023 · External reference

Pharmacological modulation of ubiquitin-proteasome pathways in oncogenic signaling

10.3390/ijms222111971 · 2021 · External reference

The roles of E3 ubiquitin ligases in cancer progression and targeted therapy

10.1002/ctm2.1204 · 2023 · External reference

A novel peroxisome-related gene signature predicts breast cancer prognosis and correlates with T cell suppression

10.2147/bctt.s490154 · 2024 · External reference

Long-chain acyl-CoA synthetases: biological functions, diseases and therapeutic targets

10.1186/s43556-025-00366-4 · 2025 · External reference

Targeting long chain acyl-CoA synthetases for cancer therapy

10.3390/ijms20153624 · 2019 · External reference

Collagen family as promising biomarkers and therapeutic targets in cancer

10.3390/ijms232012415 · 2022 · External reference

The extracellular matrix and vesicles modulate the breast tumor microenvironment

10.3390/bioengineering7040124 · 2020 · External reference